THALASSEMIA AND VENOUS THROMBOEMBOLISM

Although the life expectancy of thalassemia patients has markedly improved over the last few decades, patients still suffer from many complications of this congenital disease. The presence of a high incidence of thromboembolic events, mainly in thalassemia intermedia, has led to the identification o...

Full description

Bibliographic Details
Main Authors: Julien Succar, Khaled M. Musallam, Ali T Taher
Format: Article
Language:English
Published: Mattioli1885 2011-05-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/281
_version_ 1819001589665366016
author Julien Succar
Khaled M. Musallam
Ali T Taher
author_facet Julien Succar
Khaled M. Musallam
Ali T Taher
author_sort Julien Succar
collection DOAJ
description Although the life expectancy of thalassemia patients has markedly improved over the last few decades, patients still suffer from many complications of this congenital disease. The presence of a high incidence of thromboembolic events, mainly in thalassemia intermedia, has led to the identification of a hypercoagulable state in these patients. In this review, the molecular and cellular mechanisms leading to hypercoagulability in thalassemia are highlighted, with a special focus on thalassemia intermedia being the group with the highest incidence of thrombotic events as compared to other types of thalassemia. Clinical experience and available clues on optimal management are also discussed
first_indexed 2024-12-20T22:51:37Z
format Article
id doaj.art-2bdac75a5fba4f8eb26616f0e37d7ec0
institution Directory Open Access Journal
issn 2035-3006
language English
last_indexed 2024-12-20T22:51:37Z
publishDate 2011-05-01
publisher Mattioli1885
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj.art-2bdac75a5fba4f8eb26616f0e37d7ec02022-12-21T19:24:13ZengMattioli1885Mediterranean Journal of Hematology and Infectious Diseases2035-30062011-05-0131e2011025e201102510.4084/mjhid.2011.025173THALASSEMIA AND VENOUS THROMBOEMBOLISMJulien SuccarKhaled M. MusallamAli T TaherAlthough the life expectancy of thalassemia patients has markedly improved over the last few decades, patients still suffer from many complications of this congenital disease. The presence of a high incidence of thromboembolic events, mainly in thalassemia intermedia, has led to the identification of a hypercoagulable state in these patients. In this review, the molecular and cellular mechanisms leading to hypercoagulability in thalassemia are highlighted, with a special focus on thalassemia intermedia being the group with the highest incidence of thrombotic events as compared to other types of thalassemia. Clinical experience and available clues on optimal management are also discussedhttp://www.mjhid.org/index.php/mjhid/article/view/281
spellingShingle Julien Succar
Khaled M. Musallam
Ali T Taher
THALASSEMIA AND VENOUS THROMBOEMBOLISM
Mediterranean Journal of Hematology and Infectious Diseases
title THALASSEMIA AND VENOUS THROMBOEMBOLISM
title_full THALASSEMIA AND VENOUS THROMBOEMBOLISM
title_fullStr THALASSEMIA AND VENOUS THROMBOEMBOLISM
title_full_unstemmed THALASSEMIA AND VENOUS THROMBOEMBOLISM
title_short THALASSEMIA AND VENOUS THROMBOEMBOLISM
title_sort thalassemia and venous thromboembolism
url http://www.mjhid.org/index.php/mjhid/article/view/281
work_keys_str_mv AT juliensuccar thalassemiaandvenousthromboembolism
AT khaledmmusallam thalassemiaandvenousthromboembolism
AT alittaher thalassemiaandvenousthromboembolism